title: Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment.
authors.forename: L
authors.initials: L
authors.lastname: Cantarini
authors.forename: O M
authors.initials: OM
authors.lastname: Lucherini
authors.forename: R
authors.initials: R
authors.lastname: Cimaz
authors.forename: M
authors.initials: M
authors.lastname: Galeazzi
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D009154:Mutation; D010493:Pericarditis / Q000188:drug therapy / Q000235:genetics*; D011239:Prednisolone / Q000627:therapeutic use; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D047888:Receptors, Tumor Necrosis Factor, Type I; C506235:TNFRSF1A protein, human; D011239:Prednisolone